Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Triple Therapy Compared to Standard Pegylated Interferon Alfa 2B + Weight Based Ribavirin for Previous Nonresponders and Relapsers with Chronic Hepatitis C

Triple Therapy Compared to Standard Pegylated Interferon Alfa 2B + Weight Based Ribavirin for Previous Nonresponders and Relapsers with Chronic Hepatitis C. Hepatology. 2003; 38(4):742A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.